With an unrivalled track record of solving research challenges, our highly experienced scientific team delivers successful outcomes efficiently and quickly.
We work closely and collaboratively with ambitious life science organisations globally. See what some of them have to say about working with Domainex:
Marc Gleeson – CEO, Azura Ophthalmics
Domainex with their deep industry experience, have been able to solve complex synthetic, medicinal and analytical chemistry challenges to deliver project outcomes for Azura in a timely and efficient manner. They’ve been able to flexibly resource our program to deliver high quality results and support tight patent timelines.
Dr Julie Cherrington – Board Member, Que Oncology
Domainex have been able to flexibly resource our program to deliver high quality results in a timely and efficient manner. They have coordinated provision of a complex biophysical and biochemical data package to allow compound progression decisions to be rapidly made.
Dr David Moffat - Chief Technology officer, Macrophage Pharma
Macrophage Pharma places a high value on the integrated drug discovery services provided by Domainex. The quality of medicinal chemistry support from hit ID through to candidate nomination is extremely high, supported by excellent discovery biology and analytical functions. In a number of instances Domainex were able to provide bespoke high content cellular assays adding significant value to our projects.
Dr Rich Boyce – Senior Director of Research, PhoreMost Ltd.
Domainex is a highly valuable partner in PhoreMost’s drug discovery programmes. The company’s expertise in virtual screening, through its LeadBuilder Platform, has allowed the identification of small molecule hits to challenging biological targets which are now being pursued at PhoreMost.
Domainex’s deep knowledge and expertise in computational chemistry is enabling us to progress multiple projects quickly and cost effectively.
Dr Jack Kennefick - Co-founder & Chief Executive Officer, Tagomics
We have been really impressed with the service at Domainex, from initial discussion to delivery of the project. The Domainex team are attentive, well organised, and knowledgeable. They always take the time to understand our exact needs and consistently deliver high-quality results, in a time efficient manner.
Professor Martin Griffin - Aston University
We have been working with Domainex for a number of years now. They have always been highly professional, efficient and importantly as enthusiastic and dedicated to the work as we have been which is a good recipe for success.
Dr Richard Voellmy - CEO and CSO, HSF Pharmaceuticals SA, Switzerland
We have been working with Domainex for almost 15 years. During this time, Domainex has been our key partner for computational chemistry (LeadBuilder virtual screening and target evaluation) and lead compound improvement chemistry. The Domainex team has always been proactive, highly professional, easy to work with and has greatly benefitted our programs through its deep computational chemistry knowledge and its excellent synthetic chemistry skills. Perhaps the best testament to our successful collaboration is our joint publication in NAR (DOI: 10.1093/nar/gkx194). We certainly intend to continue this partnership.